Literature DB >> 25014692

Niacin and HDL cholesterol--time to face facts.

Donald M Lloyd-Jones1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25014692     DOI： 10.1056/NEJMe1406410

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Does metabolic syndrome increase the risk of infective complications after prostate biopsy? A critical evaluation.

Authors:  Cahit Sahin; Bilal Eryildirim; A Cihangir Cetinel; Gokhan Faydaci; Fehmi Narter; Cemal Goktas; Kemal Sarica
Journal:  Int Urol Nephrol       Date:  2015-01-15       Impact factor: 2.370

Review 2.  Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.

Authors:  Robert A Hegele; Samuel S Gidding; Henry N Ginsberg; Ruth McPherson; Frederick J Raal; Daniel J Rader; Jennifer G Robinson; Francine K Welty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-16       Impact factor: 8.311

Review 3.  Drug Therapy of Dyslipidemia in the Elderly.

Authors:  Srikanth Yandrapalli; Shashvat Gupta; Gabriela Andries; Howard A Cooper; Wilbert S Aronow
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

4.  Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study.

Authors:  John W McEvoy; Mariana Lazo; Yuan Chen; Lu Shen; Vijay Nambi; Ron C Hoogeveen; Christie M Ballantyne; Roger S Blumenthal; Josef Coresh; Elizabeth Selvin
Journal:  Int J Cardiol       Date:  2015-04-01       Impact factor: 4.164

Review 5.  Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Authors:  Richard Kones; Umme Rumana
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

6.  Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis.

Authors:  Gabriela Vazquez-Benitez; Jay R Desai; Stanley Xu; Glenn K Goodrich; Emily B Schroeder; Gregory A Nichols; Jodi Segal; Melissa G Butler; Andrew J Karter; John F Steiner; Katherine M Newton; Leo S Morales; Ram D Pathak; Abraham Thomas; Kristi Reynolds; H Lester Kirchner; Beth Waitzfelder; Jennifer Elston Lafata; Renuka Adibhatla; Zhiyuan Xu; Patrick J O'Connor
Journal:  Diabetes Care       Date:  2015-02-20       Impact factor: 19.112

7.  Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study.

Authors:  Asma Khaliq; B Delia Johnson; R David Anderson; Anthony A Bavry; Rhonda M Cooper-DeHoff; Eileen M Handberg; C Noel Bairey Merz; Stephen J Nicholls; Steven Nissen; Carl J Pepine
Journal:  Cardiovasc Endocrinol       Date:  2015-06

8.  Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update.

Authors:  Hermann Toplak; Bernhard Ludvik; Monika Lechleitner; Hans Dieplinger; Bernhard Föger; Bernhard Paulweber; Thomas Weber; Bruno Watschinger; Sabine Horn; Thomas C Wascher; Heinz Drexel; Marianne Brodmann; Ernst Pilger; Alexander Rosenkranz; Erich Pohanka; Rainer Oberbauer; Otto Traindl; Franz Xaver Roithinger; Bernhard Metzler; Hans-Peter Haring; Stefan Kiechl
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

Review 9.  Beyond Statins: Emerging Evidence for HDL-Increasing Therapies and Diet in Treating Cardiovascular Disease.

Authors:  Sterling Farrer
Journal:  Adv Prev Med       Date:  2018-07-09

10.  Positive association of familial longevity with the moderate-high HDL-C concentration in Bama Aging Study.

Authors:  Jian Wang; Liwei Shi; Yunfeng Zou; Jiexia Tang; Jiansheng Cai; Yi Wei; Jian Qin; Zhiyong Zhang
Journal:  Aging (Albany NY)       Date:  2018-11-28       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.